German OTC Price-Setting Costs Bayer $16 Million
This article was originally published in The Tan Sheet
Executive Summary
Bayer has agreed to pay an antitrust fine of more than $16 million after Germany's competition authority alleged the firm gave discounts to pharmacies that agreed to maintain specific prices for its OTC products